Literature DB >> 7500046

A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

S M Behar1, S A Porcelli, E M Beckman, M B Brenner.   

Abstract

A class of molecules that is expressed on antigen presenting cells, exemplified by CD80 (B7), has been found to provide a necessary costimulatory signal for T cell activation and proliferation. CD28 and CTLA4 are the B7 counterreceptors and are expressed on the majority of human CD4+ T cells and many CD8+ T cells. The signal these molecules mediate is distinguished from other costimulatory signals by the finding that T cell recognition of antigen results in a prolonged state of T cell unresponsiveness or anergy, unless these costimulatory molecules are engaged. However, nearly half of the CD8+ and CD4-CD8- T cells lack CD28, and the costimulatory signals required for the activation of such cells are unknown. To understand the pathways of activation used by CD28- T cells, we have examined the costimulatory requirements of antigen-specific CD4-CD8- TCR(+)-alpha/beta circulating T cells that lack the expression of CD28. We have characterized two T cell lines, DN1 and DN6, that recognize a mycobacterial antigen, and are restricted not by major histocompatibility complex class I or II, but by CD1b or CD1c, two members of a family of major histocompatibility complex-related molecules that have been recently implicated in a distinct pathway for antigen presentation. Comparison of antigen-specific cytolytic responses of the DN1 and DN6 T cell lines against antigen-pulsed CD1+ monocytes or CD1+ B lymphoblastoid cell lines (B-LCL) demonstrated that these T cells recognized antigen presented by both types of cells. However, T cell proliferation occurred only when antigen was presented by CD1+ monocytes, indicating that the CD1+ monocytes expressed a costimulatory molecule that the B-LCL transfectants lacked. This hypothesis was confirmed by demonstrating that the T cells became anergic when incubated with the CD1(+)-transfected B-LCL in the presence of antigen, but not in the absence of antigen. The required costimulatory signal occurred by a CD28-independent mechanism since both the CD1+ monocytes and CD1+ B-LCL transfectants expressed B7-1 and B7-2, and DN1 and DN6 lacked surface expression of CD28. We propose that these data define a previously unrecognized pathway of costimulation for T cells distinct from that involving CD28 and its counterreceptors. We suggest that this B7-independent pathway plays a crucial role in the activation and maintenance of tolerance of at least a subset of CD28- T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500046      PMCID: PMC2192247          DOI: 10.1084/jem.182.6.2007

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  73 in total

Review 1.  The CD1 system.

Authors:  F Calabi; A Bradbury
Journal:  Tissue Antigens       Date:  1991-01

2.  CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.

Authors:  K Harper; C Balzano; E Rouvier; M G Mattéi; M F Luciani; P Golstein
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

3.  Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction.

Authors:  J G Johnson; M K Jenkins
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

4.  Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.

Authors:  G J Freeman; F Borriello; R J Hodes; H Reiser; K S Hathcock; G Laszlo; A J McKnight; J Kim; L Du; D B Lombard
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

Review 5.  The costimulatory function of antigen-presenting cells.

Authors:  C T Weaver; E R Unanue
Journal:  Immunol Today       Date:  1990-02

Review 6.  Immunoregulatory function of human autoreactive T-cell lines and clones.

Authors:  W Strober; S P James
Journal:  Immunol Rev       Date:  1990-08       Impact factor: 12.988

Review 7.  Negative selection of lymphocytes.

Authors:  G J Nossal
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 8.  Positive selection of lymphocytes.

Authors:  H von Boehmer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

9.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

10.  Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production.

Authors:  G R Otten; R N Germain
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

View more
  33 in total

1.  Intracellular trafficking pathway of newly synthesized CD1b molecules.

Authors:  V Briken; R M Jackman; S Dasgupta; S Hoening; S A Porcelli
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages.

Authors:  Maria Teresa Ochoa; Anya Loncaric; Stephan R Krutzik; Todd C Becker; Robert L Modlin
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

3.  Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells.

Authors:  K Takahashi; K Asagoe; J Zaishun; H Yanai; T Yoshino; K Hayashi; T Akagi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC).

Authors:  F A Arosa; C Irwin; L Mayer; M de Sousa; D N Posnett
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

5.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.

Authors:  Joseph L Amprey; Gerald F Späth; Steven A Porcelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

Authors:  J A Hobbs; S Cho; T J Roberts; V Sriram; J Zhang; M Xu; R R Brutkiewicz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Galectin-3 regulates the innate immune response of human monocytes.

Authors:  Andrew W Chung; Peter A Sieling; Mirjam Schenk; Rosane M B Teles; Stephan R Krutzik; Daniel K Hsu; Fu-Tong Liu; Euzenir N Sarno; Thomas H Rea; Steffen Stenger; Robert L Modlin; Delphine J Lee
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

8.  Regulation of CD1 antigen-presenting complex stability.

Authors:  Artur N Odyniec; Duarte C Barral; Salil Garg; Raju V Tatituri; Gurdyal S Besra; Michael B Brenner
Journal:  J Biol Chem       Date:  2010-02-04       Impact factor: 5.157

9.  Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules.

Authors:  Arthur Kaser; David L Hava; Stephanie K Dougan; Zhangguo Chen; Sebastian Zeissig; Michael B Brenner; Richard S Blumberg
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

10.  The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle.

Authors:  Thi Kim Anh Nguyen; Ad P Koets; Wiebren J Santema; Willem van Eden; Victor P M G Rutten; Ildiko Van Rhijn
Journal:  Vaccine       Date:  2009-06-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.